» Articles » PMID: 38775460

Masks and Respirators for Prevention of Respiratory Infections: a State of the Science Review

Abstract

SUMMARYThis narrative review and meta-analysis summarizes a broad evidence base on the benefits-and also the practicalities, disbenefits, harms and personal, sociocultural and environmental impacts-of masks and masking. Our synthesis of evidence from over 100 published reviews and selected primary studies, including re-analyzing contested meta-analyses of key clinical trials, produced seven key findings. First, there is strong and consistent evidence for airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory pathogens. Second, masks are, if correctly and consistently worn, effective in reducing transmission of respiratory diseases and show a dose-response effect. Third, respirators are significantly more effective than medical or cloth masks. Fourth, mask mandates are, overall, effective in reducing community transmission of respiratory pathogens. Fifth, masks are important sociocultural symbols; non-adherence to masking is sometimes linked to political and ideological beliefs and to widely circulated mis- or disinformation. Sixth, while there is much evidence that masks are not generally harmful to the general population, masking may be relatively contraindicated in individuals with certain medical conditions, who may require exemption. Furthermore, certain groups (notably D/deaf people) are disadvantaged when others are masked. Finally, there are risks to the environment from single-use masks and respirators. We propose an agenda for future research, including improved characterization of the situations in which masking should be recommended or mandated; attention to comfort and acceptability; generalized and disability-focused communication support in settings where masks are worn; and development and testing of novel materials and designs for improved filtration, breathability, and environmental impact.

Citing Articles

Cost-effectiveness of preventive COVID-19 interventions: a systematic review and network meta-analysis of comparative economic evaluation studies based on real-world data.

Tang X, Sun S, Memedi M, Hiyoshi A, Montgomery S, Cao Y J Glob Health. 2025; 15:04017.

PMID: 39977668 PMC: 11842005. DOI: 10.7189/jogh.15.04017.


Adherence to mask-wearing and its impact on the incidence and deaths of viral respiratory infectious diseases: a systematic review, meta-analysis and modelling study.

Chen C, Zhou W, Qi J, Chen M, Yuan Z, Miao J BMJ Glob Health. 2025; 10(2).

PMID: 39971586 PMC: 11840920. DOI: 10.1136/bmjgh-2024-017087.


Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19.

Nakayama E, Shioda T Pathogens. 2025; 13(12.

PMID: 39770368 PMC: 11728538. DOI: 10.3390/pathogens13121109.


Commentary: Without Values, Complexity is Reduced to Mathematics.

Greenhalgh T J Eval Clin Pract. 2024; 31(1):e14263.

PMID: 39663878 PMC: 11635397. DOI: 10.1111/jep.14263.


Seasonal Influenza in Children With Cancer.

Daniels P, Danziger-Isakov L, Otto W Cureus. 2024; 16(10):e72785.

PMID: 39618559 PMC: 11608092. DOI: 10.7759/cureus.72785.


References
1.
Nie Z, Chen Y, Deng M . Quantitative evaluation of precautions against the COVID-19 indoor transmission through human coughing. Sci Rep. 2022; 12(1):22573. PMC: 9803700. DOI: 10.1038/s41598-022-26837-0. View

2.
Du H, Huang S, Wang J . Environmental risks of polymer materials from disposable face masks linked to the COVID-19 pandemic. Sci Total Environ. 2022; 815:152980. PMC: 8741336. DOI: 10.1016/j.scitotenv.2022.152980. View

3.
Majeed B, David J, Bragazzi N, McCarthy Z, Grunnill M, Heffernan J . Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach. Front Public Health. 2023; 10:1086849. PMC: 9845909. DOI: 10.3389/fpubh.2022.1086849. View

4.
Aiello A, Perez V, Coulborn R, Davis B, Uddin M, Monto A . Facemasks, hand hygiene, and influenza among young adults: a randomized intervention trial. PLoS One. 2012; 7(1):e29744. PMC: 3266257. DOI: 10.1371/journal.pone.0029744. View

5.
Greenhalgh T, Fisman D, Cane D, Oliver M, MacIntyre C . Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent. BMJ Evid Based Med. 2022; . PMC: 9510422. DOI: 10.1136/bmjebm-2022-111952. View